Could you expand on what you think MNTA will "discover" that will prompt Amphastar (and MNTA, to be sure) to settle out of court?
Here's my WAG,
Amphastar has to have a process for accurately characterizing their molecule. If they use a process that infringes on Momenta's patent(s), Amphastar will have to settle. It doesn't matter that Amphastar may have come up with an accurate process independently, it's a matter of patent protection.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.